Key Drivers
- Margin recovery
- Cash generation
- Intangible overhang
AIAI Summary
NEOG now looks more like a credible turnaround than a broken story, with core Food Safety growth, 47% gross margin, and positive free cash flow signaling real stabilization, but the investment case still hinges on flawless execution as the stock remains technically weak and the recovery is not yet fully proven.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin recovery
- •Cash generation
- •Intangible overhang
NEOG's latest quarter showed clear improvement in margins and cash flow, with operating losses narrowing and liquidity staying strong, but profitability remains unproven and the valuation still depends on a sustained turnaround.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Failed rebounds
- •Support test
NEOG remains technically weak, with lower highs and lower lows, failed rebounds, and a key test of support near $8.2 while $9.0-$9.5 caps upside. క
Sharp fade from the early-May rebound into the 2026-05-15 close signals weakening momentum
Sentiment & News
Key News Insights:
- •AOAC validation
- •Rapid detection
- •Broader adoption
Neogen's Listeria Right Now™ test gained AOAC certification, validating enrichment-free Listeria detection and likely supporting broader adoption in food safety monitoring.
This certification should strengthen confidence in Neogen's Listeria monitoring solution and help drive wider market acceptance
Similar Companies in Healthcare
Other companies in the same sector with AI ratings